796 related articles for article (PubMed ID: 29953746)
1. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
2. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
3. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
5. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
[TBL] [Abstract][Full Text] [Related]
7. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
8. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
10. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
Allen KJ; Cappel MA; Killian JM; Brewer JD
Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
[TBL] [Abstract][Full Text] [Related]
12. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions.
Dika E; Veronesi G; Patrizi A; De Salvo S; Misciali C; Baraldi C; Mussi M; Fabbri E; Tartari F; Lambertini M
Dermatol Ther; 2020 Jul; 33(4):e13474. PubMed ID: 32391961
[TBL] [Abstract][Full Text] [Related]
13. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
14. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
[TBL] [Abstract][Full Text] [Related]
16. Recurrent basal cell carcinoma after incomplete resection.
Robinson JK; Fisher SG
Arch Dermatol; 2000 Nov; 136(11):1318-24. PubMed ID: 11074691
[TBL] [Abstract][Full Text] [Related]
17. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2020 Sep; 83(3):832-838. PubMed ID: 31600531
[TBL] [Abstract][Full Text] [Related]
18. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma.
Bieley HC; Kirsner RS; Reyes BA; Garland LD
J Am Acad Dermatol; 1992 May; 26(5 Pt 1):754-6. PubMed ID: 1583176
[TBL] [Abstract][Full Text] [Related]
19. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
[TBL] [Abstract][Full Text] [Related]
20. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
